Peptide health risks, vaccines, UnitedHealth: Morning Rounds
White House proposes 12% cut in Department of Health and Human Services budget
The White House has released its proposed 2027 federal budget, which includes a 12% cut in spending on the Department of Health and Human Services. This budget plan includes deep cuts to the National Institutes of Health, the elimination of a health research agency, and the creation of a new agency called the Administration for a Healthy America, focused on chronic diseases.
STAT’s Chelsea Cirruzzo and John Wilkerson provide a detailed overview of the proposal and analyze the likelihood of Congress approving it. Megan Molteni and Anil Oza delve into the specifics of the proposed cuts to the NIH.
Ethical concerns raised over Guinea-Bissau hep B trial
The University of Southern Denmark is seeking assistance in evaluating the ethics of a clinical trial proposed to be conducted in Guinea-Bissau using CDC funding. The trial aims to randomize babies to receive the first dose of the hepatitis B vaccine at birth or at two months of age. While the trial has been deemed unethical by the WHO and others, the university is exploring independent ethical assessment options.
The trial seeks to uncover any potential negative consequences of administering the hepatitis B vaccine at birth, a practice that has been standard in Guinea-Bissau. The vaccine is known to be safe and effective in preventing chronic hepatitis B infection in young children.
UnitedHealth Group expands AI initiatives
UnitedHealth Group is ramping up its AI efforts, with job openings in cybersecurity, claims review, fraud detection, and more. The company already employs over 22,000 software engineers globally, with a significant percentage utilizing AI in their work. This push for AI adoption in healthcare reflects a broader trend in the industry.
Chief investigative reporter Casey Ross explores the potential benefits and risks of widespread AI adoption in healthcare. Patients may face challenges in understanding the impact of AI on their care, raising important ethical considerations.
RFK Jr. advocates for peptides while expressing skepticism towards vaccines
Robert F. Kennedy Jr. and his supporters advocate for natural health choices, emphasizing nutrition and vitamins over vaccines. However, Kennedy has shown support for peptides, experimental drugs that have not been extensively studied for efficacy or potential side effects.
STAT’s Sarah Todd delves into the apparent contradiction in Kennedy’s stance on peptides versus vaccines, exploring themes of medical libertarianism and folk pharmacology. The debate highlights the complexities of healthcare decision-making.
Improving care for children in psychosis
A mother shares her experience navigating the healthcare system while seeking treatment for her son’s psychosis. Liz Koch reflects on the challenges of advocating for her child within a flawed pediatric healthcare system, calling for improved support for families facing similar struggles.
Raw Farm issues recall amid E. coli outbreak
After resisting a recall request from the FDA, Raw Farm has finally issued a voluntary recall of its unpasteurized cheese products linked to an E. coli outbreak. The farm faced scrutiny for delaying the recall, highlighting concerns about food safety and regulatory compliance.
For further reading:
- How gender-affirming care is becoming a political test for medical groups – The 19th
- The challenges of dementia and end-of-life care – The Atlantic
- The impact of FDA delays on a biotech company – STAT
- ACA subsidy recipients face tax surprises – KFF Health News
- First Opinion: Challenges in accessing medical nutrition – STAT



